DeCure's autonomous Neuro AI scientist is researching a drug-repurposing hypothesis for cranial nerve neuropathy — screening already-approved drugs against its 1-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleCranial nerve neuropathy maps to a 1-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
No approved-drug candidate for cranial nerve neuropathy is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
Molecular view
gelsolin (GSN) — GSN is one of the genes genetically linked to this disease in Open Targets — shown as context, not as a drug target we're pursuing: no approved-drug candidate for this disease is yet corroborated in the literature we found.
Loading structure…
helix sheet apo structuredrag to rotate · scroll to zoom
RCSB Protein Data Bank · entry 6Q9R · 2.73 Å · ligand none (apo structure). Experimental structure, not a prediction.
What the evidence adds up to
A 2000 report describes a single patient with Charcot-Marie-Tooth disease type 1 who carried an EGR2 gene mutation (Arg381His) and presented with cranial nerve deficits. The authors note that EGR2 is involved in myelinogenesis and hindbrain development, and they interpret the case as supporting a role for EGR2 in cranial nerve development. No treatment or outcome data are given for this patient.
Two reports from 1989 and 2008 describe small case series of patients with idiopathic or infection-associated multiple cranial neuropathies. The 1989 series includes 8 patients, the 2008 series 12 patients. In both, the symptoms were self-limiting, and corticosteroid therapy appeared to hasten recovery in those who received it, though a few patients in each series were left with residual neurological deficits. The 2008 report notes that most cases followed a mild respiratory infection and that the facial and optic nerves were most commonly affected. Neither series reports a controlled trial or a consistent, quantified outcome.
A 2017 case report describes a single patient with recurrent painful ophthalmoplegic neuropathy (RPON) involving the fourth and sixth cranial nerves only. The cause of RPON remains unclear, and the authors note debate over whether it is neuropathic or migrainous. No treatment or outcome is reported for this patient.
Two review articles from 2017 and 2020 discuss the use of radiographic imaging, particularly MRI, to evaluate cranial neuropathies. They provide anatomical and diagnostic frameworks but report no patient outcomes or treatment data. The 2017 review notes that indications for imaging vary considerably between cranial nerves and that 49,079 articles were retrieved in a database search, but no single diagnostic yield figure is given.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
Neurology · 2000 · 87 citations · open access
Cranial nerve involvement in CMT disease type 1 due to early growth response 2 gene mutation
AbstractMutations in the gene coding for the Schwann cell transcription factor early growth response 2 (EGR2), which seems to regulate myelinogenesis and hindbrain development, have been observed in few cases of inherited neuropathy. The authors describe a unique combination of cranial nerve deficits in one member of a Charcot-Marie-Tooth 1 family carrying an EGR2 mutation (Arg381His). This finding further supports the role of EGR2 in cranial nerve development.
AbstractRecurrent painful ophthalmologic neuropathy (RPON), previously termed ophthalmoplegic migraine, is characterised by repeated attacks of one or more ocular cranial nerve palsies with ipsilateral headache. Its cause remains unclear; it is currently thought to be neuropathic in origin, but there is debate in the literature. In documented cases, a third cranial nerve palsy is by far the most common. Here we present a case of RPON involveing the fourth and sixth cranial nervesonly. Thorough investigation, including MR scan of brain and lumbar puncture, found no alternative explanation. This case adds to the debate over whether the cause of RPON is truly neuropathic or migrainous.
AbstractA report of 12 patients with recurrent multiple cranial neuropathy is presented. In most cases the palsies a accompanied a mild respiratory infection. Both motor and sensory cranial nerves were affected, the facial nerve and optic nerve being the most common. The symptoms were self-limited in course and steroid therapy seemed to hasten the recovery in the cases it was used. Only in a few cases a noticeable neurological deficiency remained. Aetiological aspects of the syndrome are discussed.
Guidelines for Radiographic Imaging of Cranial Neuropathies
AbstractDisruption of the complex pathways of the 12 cranial nerves can occur at any site along their course, and many, varied pathologic processes may initially manifest as dysfunction and neuropathy. Radiographic imaging (computed topography or magnetic resonance imaging) is frequently used to evaluate cranial neuropathies; however, indications for imaging and imaging method of choice vary considerably between the cranial nerves. The purpose of this review is to provide an analysis of the diagnostic yield and the most clinically appropriate means to evaluate cranial neuropathies using radiographic imaging. Using the PubMed MEDLINE NCBI database, a total of 49,079 articles' results were retrieved on September 20, 2014. Scholarly articles that discuss the etiology, incidence, and use of imaging in the context of evaluation and diagnostic yield of the 12 cranial nerves were evaluated for the purposes of this review. We combined primary research, guidelines, and best practice recommendations to create a practical framework for the radiographic evaluation of cranial neuropathies.
Journal of the Korean Society of Radiology · 2020 · 6 citations · open access
Normal Anatomy of Cranial Nerves III–XII on Magnetic Resonance Imaging
AbstractBecause of the inherent complex anatomy and functional arrangement of the cranial nerves (CNs), neuroimaging of cranial neuropathy is challenging. With recent advances in magnetic resonance imaging (MRI) techniques, the cause of cranial neuropathy can now be detected in many cases. As an active multidisciplinary team member of cranial neuropathy, it is essential for the neuroradiologist to be familiar with the detailed anatomy of the CNs on MRI. This review contains the basic MRI anatomy of CNs III-XII according to a segmental classification from the brain stem to the extracranial region. The optimal imaging options to best evaluate the specific segment of the CNs will also be discussed briefly.
Japanese Journal of Medicine · 1989 · 1 citations · open access
Idiopathic multiple cranial neuropathy a twenty year experience.
AbstractA report on 8 patients with idiopathic multiple cranial neuropathy is presented. The syndrome consists of headache, facial pain and diplopia preceding the onset of cranial nerve palsy. The cranial nerves most frequently involved were the third, fifth and seventh. All patients were treated with corticosteroid therapy. The symptoms were self-limiting in their course and corticosteroid therapy appeared to hasten recovery of function. Only in a few cases a noticeable neurological deficiency remained. Differential diagnosis and etiological considerations are discussed.
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.
